|
RU2732245C1
|
|
Novel compositions of n-carbamoylmethyl-4-phenyl-2-pyrrolidone for treating and preventing obesity
|
|
RU2542419C1
|
|
Pantocalcin, nootropic agent in liquid form
|
|
RU2537136C1
|
|
Method of obtaining alimemazine tartrate solution for introduction by injection
|
|
RU2536258C1
|
|
Method for preparing teriflunomide tablets
|
|
RU2536254C1
|
|
Retard tablets of trimebutine
|
|
RU2539375C1
|
|
Tabletted pharmaceutical composition and method for producing it
|
|
RU2530626C1
|
|
Pharmaceutical composition of s1p receptor agonist for treating demyeliniating diseases
|
|
RU2524651C1
|
|
Pharmaceutical composition in form of solution for injection and method for production thereof
|
|
RU2536269C1
|
|
Composition for treating disturbed innervation (versions)
|
|
RU2509560C1
|
|
New therapeutic combinations of mirtazapine applicable in pain conditions
|
|
RU2506077C1
|
|
Combination for prevention, correction and therapy of pain related to neurodegeneration or associated with somatoform disorders
|
|
RU2493845C1
|
|
Composition for treating multiple sclerosis (versions)
|
|
RU2488388C1
|
|
Pharmaceutical composition for preventing and treating mental, behaviour and cognitive disorders
|
|
RU2471482C1
|
|
Composition for treating multiple sclerosis (versions)
|
|
RU2481124C1
|
|
Pharmaceutical combination of atorvastatin and nicergolin for preventing or treating cerebrovascular disease
|
|
RU2448706C2
|
|
Injection form of pharmaceutical composition (versions) for preventing and treating neuropathies and method for preparing it
|
|
RU2393855C1
|
|
Anxiolytic and cerebroprotective agent reducing inclination to alcohol
|
|
RU2381034C1
|
|
Pharmaceutical composition for treating vascular complications of diabetes and diabetic polyneuropathy
|
